sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
25-May-2016 09:10
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 426-450 out of 1248.

<< < 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 > >>

Public Release: 28-Sep-2015
Canadian Medical Association Journal
Universal TB screening of immigrants to Canada costly, inefficient
Canada's blanket practice of screening all newly arriving immigrants for tuberculosis is highly inefficient and should focus on only those arriving from countries with high rates of TB, according to research published in CMAJ (Canadian Medical Association Journal).

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
613-520-7116
Canadian Medical Association Journal

Public Release: 28-Sep-2015
Journal of the American College of Cardiology
Study examines impact of global food consumption on heart disease
More than 80 percent of cardiovascular disease deaths occur in low- and middle-income countries, but very little data on the impact of diet on cardiovascular disease exists from these countries.

Contact: Nicole Napoli
nnapoli@acc.org
202-375-6523
American College of Cardiology

Public Release: 25-Sep-2015
Lancet
Countries have a long way to go to reduce the burden of NCD (non-communicable disease)
The global pandemic of non-communicable diseases, which is progressing most rapidly in low-income and middle-income countries, led the UN to issue a political declaration on the need to counter the crisis. A new method published today in the Lancet shows that many nations have a long way to go to reduce suffering and deaths from NCD.
United Health Foundation

Contact: Sheree Bryant
sheree.bryant@c3health.org
C3 Collaborating for Health

Public Release: 22-Sep-2015
eLife
New study maps the progression of Parkinson's disease within the brain
Scientists at the Montreal Neurological Institute and Hospital -- The Neuro, at McGill University and the McGill University Health Centre, have made advances in understanding the process involved in the progression and spread of Parkinson's disease within the brain.

Contact: Maya-Olivia Eyssen
maya-olivia.eyssen@mcgill.ca
514-398-3376
McGill University Health Centre

Public Release: 22-Sep-2015
Microbial Genomics
Superbug study reveals how E. coli strain acquired deadly powers
A strain of E. coli became a potentially fatal infection in the UK around 30 years ago, when it acquired a powerful toxin, a gene study has revealed.
Food Standards Agency, Food Standards Scotland

Contact: Anna Borthwick
anna.borthwick@ed.ac.uk
44-131-650-2246
University of Edinburgh

Public Release: 21-Sep-2015
Molecular Biology of the Cell
Van Andel Research Institute, University of Toledo find way to combat brain cancer
Scientists at the University of Toledo Health Science Campus (UT) and Van Andel Research Institute (VARI) have discovered an innovative way that may stop the spread of the most lethal and aggressive brain cancer glioblastoma multiforme (GBM). In laboratory studies, scientists demonstrated that activating a specific family of proteins halted cancer cell migration into healthy tissue.

Contact: Beth Hinshaw-Hall
Beth.HinshawHall@vai.org
616-234-5519
Van Andel Research Institute

Public Release: 21-Sep-2015
Emerging Infectious Diseases
Malaria: Multi-drug resistance more alarming than ever
The efforts of the international community for the past ten years in the fight against malaria have reduced the number of disease-related deaths. The in vitro examination of a strain of parasites solely exposed to artemisinin (the base compound for standard therapy) demonstrates the development of a widespread resistance to most other anti-malarial drugs.

Contact: Françoise Benoit-Vical
Francoise.Vical@inserm.fr
INSERM (Institut national de la santé et de la recherche médicale)

Public Release: 18-Sep-2015
Science
A new understanding of dengue virus
An international consortium of scientists, including researchers from the University of Texas Medical Branch at Galveston, worked to map out the antigenic differences in various strains of dengue virus.

Contact: Christopher Smith Gonzalez
chrissmi@UTMB.EDU
409-772-8790
University of Texas Medical Branch at Galveston

Public Release: 18-Sep-2015
British Journal of Nutrition
Maternal protein deficiency during pregnancy 'memorized' by fetal muscle cells
Research in rat models confirms a molecular link between activation of the amino acid response signal and the cell autophagy pathway, which is transferred from pregnant mothers' skeletal muscles to the placenta and the fetus.

Contact: Sharita Forrest
slforres@illinois.edu
217-244-1072
University of Illinois at Urbana-Champaign

Public Release: 17-Sep-2015
Infection and Immunity
E. coli more virulent when accompanied by beneficial bacteria
Scientists wonder why some people get so sick and even die after being infected by the foodborne pathogen E. coli O157:H7, while others experience much milder symptoms and recover relatively quickly. Now Penn State's College of Agricultural Sciences researchers believe they have discovered an explanation.
US Department of Agriculture

Contact: A'ndrea Elyse Messer
aem1@psu.edu
814-865-9481
Penn State

Public Release: 17-Sep-2015
The Breast
Study finds high proportion of advanced breast cancers in sub-Saharan Africa
In one of the first studies of its kind, a new report finds a large majority of breast cancers in Cote d'Ivoire and Republic of Congo are detected only after they've become advanced.
The African Cancer Registry Network

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society

Public Release: 17-Sep-2015
IDRI, Wellcome Trust team for tuberculosis vaccine trial in South Africa
Today, the Infectious Disease Research Institute (IDRI) and Wellcome Trust announce the start of a Phase 2a trial in South Africa of IDRI's tuberculosis vaccine candidate, which has been shown to both prevent and treat TB in preclinical studies in animal models. The Wellcome Trust awarded IDRI a $5.8 million/£3.8 million grant to clinically assess the ability of IDRI's vaccine candidate to reduce TB recurrence after treatment.
Wellcome Trust

Contact: Lee Schoentrup
lee.schoentrup@idri.org
206-858-6064
Infectious Disease Research Institute

Public Release: 17-Sep-2015
Science
Global consortium rewrites the 'cartography' of dengue virus
An international consortium of laboratories worldwide that are studying the differences among dengue viruses has shown that while the long-held view that there are four genetically-distinct types of the virus holds, far more important are the differences in their antigenic properties -- the 'coats' that the viruses wear that help our immune systems identify them.

Contact: Sarah Collins
researchcommunications@admin.cam.ac.uk
44-012-233-32300
University of Cambridge

Public Release: 17-Sep-2015
PLOS Neglected Tropical Diseases
Global burden of leptospirosis is greater than thought, and growing
The global burden of a tropical disease known as leptospirosis is far greater than previously estimated, resulting in more than 1 million new infections and nearly 59,000 deaths annually, a new international study led by the Yale School of Public Health has found.

Contact: Michael Greenwood
michael.greenwood@yale.edu
203-737-5151
Yale University

Public Release: 16-Sep-2015
Scientific Reports
Scientists create immunity to deadly parasite by manipulating host's genes
Researchers have silenced genes within human cells to induce immunity to the parasite E. histolytica, demonstrating the effectiveness of an entirely new approach to protecting people from infectious diseases.

Contact: Josh Barney
jdb9a@virginia.edu
434-906-8864
University of Virginia Health System

Public Release: 16-Sep-2015
HIV cure, better therapies subjects of $6.3 million in grants to Pitt vaccine scientist duo
A husband-wife team researching a cure for HIV/AIDS at the University of Pittsburgh Center for Vaccine Research recently received $6.3 million total in two grants from the National Institutes of Health. The grants are the latest in the team's successful run garnering NIH support for their HIV research, now totaling $23 million since they came to Pitt six years ago.
National Institutes of Health

Contact: Allison Hydzik
HydzikAM@upmc.edu
412-647-9975
University of Pittsburgh Schools of the Health Sciences

Public Release: 15-Sep-2015
mBio
Skin microbiome influences common sexually transmitted disease
For years, researchers have known that the human skin is home to a diverse community of microorganisms, collectively known as the skin microbiome. Now a new study has shown that individuals with a particular skin microbiome can effectively clear bacteria that cause chancroid, a sexually transmitted disease common in the developing world that has been linked to enhanced HIV transmission.

Contact: Aleea Khan
communications@asmusa.org
202-942-9297
American Society for Microbiology

Public Release: 15-Sep-2015
PLOS Medicine
Electronic reminders keep TB patients on track with medication in China
Giving electronic reminders to tuberculosis patients in China can reduce the amount of medication doses they miss by half, according to new research from the London School of Hygiene & Tropical Medicine and the National Center for Tuberculosis Control and Prevention in China.
Bill & Melinda Gates Foundation

Contact: Katie Steels
press@lshtm.ac.uk
44-020-792-72802
London School of Hygiene & Tropical Medicine

Public Release: 14-Sep-2015
UNITAID and EGPAF launch initiative to significantly scale up early infant HIV diagnosis
UNITAID and the Elizabeth Glaser Pediatric AIDS Foundation today launched an initiative that will dramatically scale up HIV diagnosis among newborns in nine African countries. In partnership with ministries of health, this initiative will make 'point-of-care' testing more widely available to HIV-exposed infants early in their lives, when they are most at risk of dying, and enable those diagnosed with the virus to be put on lifesaving treatment more quickly.

Contact: Johanna Harvey
jharvey@pedaids.org
202-280-1657
Elizabeth Glaser Pediatric AIDS Foundation

Public Release: 11-Sep-2015
Health Affairs
Achieving effective health care with a new approach to caring for chronic illnesses
Researchers from the University of Miami and Harvard University address the challenges of effective universal health coverage in low- and middle-income countries, focusing on solving one of the most pressing issues: the care of chronic illnesses. Their suggestions, aimed at strengthening health care systems, include recommendations based on a 'diagonal approach' for managing health care.

Contact: Megan Ondrizek
m.ondrizek@umiami.edu
305-284-3667
University of Miami

Public Release: 11-Sep-2015
Cell Reports
Ebola virus mutations may help it evade drug treatment
Genetic mutations called 'escape variants' in the deadly Ebola virus appear to block the ability of antibody-based treatments to ward off infection, according to a team of US Army scientists and collaborators. Their findings, published online this week in the journal Cell Reports, have implications for the continued development of therapeutics to treat Ebola virus disease, which has claimed the lives of over 11,000 people in West Africa since last year.
Defense Threat Reduction Agency

Contact: Caree Vander Linden
teresa.l.vanderlinden.civ@mail.mil
301-619-2285
US Army Medical Research Institute of Infectious Diseases

Public Release: 11-Sep-2015
Angewandte Chemie
A better class of cancer drugs
A class of therapeutic drugs known as protein kinase inhibitors has become a powerful weapon in the fight against various life-threatening diseases. One problem with these drugs, however, is that they often inhibit many different targets, which can lead to side effects and complications in therapeutic use. A recent study by SDSU chemist Jeffrey Gustafson has identified a new technique for improving the selectivity of these drugs and possibly decreasing unwanted side effects in the future.

Contact: Beth Chee
bchee@mail.sdsu.edu
619-594-4563
San Diego State University

Public Release: 10-Sep-2015
Malaria Journal
African dams linked to over 1 million malaria cases annually
A new peer-reviewed study that for the first time correlates the location of large dams with the incidence of malaria and quantifies the impacts across sub-Saharan Africa. The study looked at over 1,200 dams and found that the population at risk for malaria around dams is at least four times greater than previously estimated.

Contact: James Clarke
j.clarke@cgiar.org
94-077-336-9533
Burness

Public Release: 10-Sep-2015
Lancet
Poor diet and high blood pressure now number 1 risk factors for death
New global burden of disease study finds a huge amount of deaths worldwide are due to preventable risk-factors.

Contact: Jane Gardner
gardner.j@unimelb.edu.au
041-175-8984
University of Melbourne

Public Release: 10-Sep-2015
Cancer Epidemiology
Breast cancer incidence, death rates rising in some economically transitioning countries
A new study finds breast cancer incidence and death rates are increasing in several low and middle income countries, even as death rates have declined in most high income countries, despite increasing or stable incidence rates.
American Cancer Society

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society

Showing releases 426-450 out of 1248.

<< < 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 > >>